Have a read of the 8th June 2022 announcement of the first boy receiving treatment. It explains what happens.
Effectively after 24 weeks they transition into an open lable expansion trial receiving either a 25 or 50 dose of atl1102. Any placebo dosing would finish and be replaced.
6 months passed since first patient, page-3
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
-0.003(3.45%) |
Mkt cap ! $76.63M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 8.7¢ | 8.4¢ | $77.77K | 918.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 212500 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.4¢ | 189926 | 1 |
View Market Depth
| Last trade - 12.12pm 02/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |